缩小非传染性疾病方面的执行差距

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-06-18 DOI:10.1038/s41591-025-03652-4

Bente Mikkelsen, Pavel Ursu, Claire Chaumont, Jennifer L. Sargent, Melanie Y. Bertram, Leanne M. Riley, Taskeen Khan, Jennifer Horton, Amanda Shriwise

引用次数: 0

摘要

将重点放在非传染性疾病的实施上，有助于到2050年将全世界过早死亡的概率降低50%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Bridging the implementation gap in non-communicable diseases

查看原文本刊更多论文

Bridging the implementation gap in non-communicable diseases

A focus on implementation for non-communicable diseases could help to deliver a 50% reduction in the probability of premature mortality worldwide by 2050.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.